Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

South Africa will launch Lenacapavir, a six-month HIV prevention injection, in six provinces, targeting all HIV-negative individuals to curb new infections.

Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

By Chris Takudzwa Muronzi HARARE, Feb 19 (Reuters) - Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the country one of the first ...

Key goals of EHE include, from 2017 to the end of 2025, reducing new HIV infections and diagnoses by 75%, increasing viral suppression among PWH to 95%, and increasing good or better self-rated health ...

While medical breakthroughs have made ending HIV transmission a realistic goal, experts warn that stigma and misinformation ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

WASHINGTON (AP) — District of Columbia Mayor Muriel Bowser is set to announce a new effort to fight HIV and AIDS. The HIV rate in the nation’s capital has declined dramatically in recent years, but it ...

"We must recommit our nation to eliminate health disparities and end the HIV/AIDS epidemic." ...

Observers are calling proposed changes to state-funded HIV assistance its biggest rollback since the aid went into place.